Morbid Obesity

Intragastric stimulation (IGS) safe treatment for morbid obesity

Published in Obesity and Diabetes Week, March 3rd, 2003

According to recent research from Austria, "The technique of implantable gastric stimulator (IGS) placement for treatment of morbid obesity is described. There are three components of the IGS, the programming system, the lead and the electrical stimulator itself."

"It is placed in the anterior abdominal wall," said K. Miller and collaborators at the A. o. Krankenhaus Hallein und Ludwig-Boltzmann-Institut fur Gastroenterologie und experimentelle Chirurgie. "It is connected to the bipolar lead that is positioned in the muscle wall of the stomach. The nominal parameters were: pulse width 208 microseconds 24 hours per day, pulse rate 40 Hertz, and amplitude 6.2-10.0...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week

Source: Obesity and Diabetes Week (2003-03-03)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry